Market Overview

Why Miragen's Stock Is Trading Higher Today

Why Miragen's Stock Is Trading Higher Today

Miragen Therapeutics (NASDAQ: MGEN) shares are trading higher on Wednesday after the company announced it is acquiring Viridian Therapeutics. No terms were disclosed.

Miragen Therapeutics Inc is a US-based clinical-stage biopharmaceutical company discovering and developing proprietary RNA (Ribonucleic acid)-targeted therapies with a specific focus on microRNAs and their role in diseases where there is a high unmet medical need. Its clinical-stage product candidates include Cobomarsen (MRG-106), Remlarsen (MRG-201), MRG-229, and MRG-110. The company mainly focuses on developing such therapeutics which will target blood cancers, pathological fibrosis, and revascularization.

Miragen Therapeutics shares traded up 87.32% to 97 cents on Wednesday at the time of publication. The stock has a 52-week high of $2.27 and a 52-week low of 31 cents.


Related Articles (MGEN)

View Comments and Join the Discussion!

Posted-In: why it's movingM&A News Penny Stocks